Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)
CUSIP: 53630X203
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 5,578,947
- Total 13F shares
- 529,307
- Share change
- +851
- Total reported value
- $1,512,291
- Price per share
- $2.85
- Number of holders
- 21
- Value change
- +$2,462
- Number of buys
- 7
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 53630X203?
CUSIP 53630X203 identifies LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 53630X203:
Top shareholders of LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
224,876
|
$710,609 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.6%
|
89,272
|
$282,100 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
61,076
|
$193,026 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.82%
|
46,019
|
$145,420 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
34,797
|
$109,959 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.43%
|
23,862
|
$75,404 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
18,626
|
$58,858 | — | 30 Jun 2025 | |
| Morgan R. Brown |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
176,000
|
$46,746 | — | 07 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
13,160
|
$41,586 | — | 30 Jun 2025 | |
| Jeffrey Arvin Fink |
3/4/5
|
Director |
—
class O/S missing
|
11,526
|
$36,883 | — | 04 Jun 2025 | |
| Richard Dana Ono |
3/4/5
|
Director |
—
class O/S missing
|
11,526
|
$36,883 | — | 04 Jun 2025 | |
| George Nomikos |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
125,000
|
$33,200 | — | 01 Nov 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
9,412
|
$29,742 | — | 30 Jun 2025 | |
| Jill M. Jene |
3/4/5
|
Director |
—
class O/S missing
|
7,174
|
$22,956 | — | 04 Jun 2025 | |
| Spyros Papapetropoulos |
3/4/5
|
Director |
—
class O/S missing
|
7,174
|
$22,956 | — | 04 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
2,587
|
$8,175 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
2,287
|
$7,226 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
673
|
$2,127 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
575
|
$1,817 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
475
|
$1,501 | — | 30 Jun 2025 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0.01%
|
471
|
$1,488 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
162
|
$512 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
67
|
$212 | — | 30 Jun 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
59
|
$186 | — | 30 Jun 2025 |
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q3 2025
As of 30 Sep 2025,
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
529,307 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, DIMENSIONAL FUND ADVISORS LP, and BARCLAYS PLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
18
Q3 2025 holders
21
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.